Triple-Negative Breast Cancer: effects of Tamoxifen in the lysosomal pathway

HISTAMINE MODULATES INTRATUMOR MICROBIOTA IN 4T1 TRIPLE NEGATIVE BREAST CANCER

Metronomic chemotherapy combining paclitaxel and a muscarinic agonist for triple negative breast cancer treatment

Targeting ID4 to Reprogram Triple-Negative Breast Cancer for Endocrine Therapy Sensitivity

Recovery of specific miRNAs in heparinized plasma obtained from HER2+ breast cancer patients who underwent neoadjuvant therapy protocol.

Thyroid hormones modulate breast cancer metastasis formation by regulating the immune subset distribution in the lungs

Targeting RAC1: A Promising therapeutic approach for Triple-Negative Breast Cancer

Norcantharidin: a promising natural compound for the treatment triple negative breast cancer.

The Molecular Mechanism of Protein Phosphatase PP2A as a Potential Therapeutic Target to Counteract Metastasis in Breast Cancer

Metronomic chemotherapy in TNBC MDA-MB231 cells exposed to nicotine. Nitric Oxide Synthase participation.